ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 72 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 2.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $378,679 | -20.2% | 63,966 | 0.0% | 0.01% | -18.2% |
| Q2 2023 | $474,628 | -21.5% | 63,966 | 0.0% | 0.01% | -31.2% |
| Q1 2023 | $604,479 | -36.2% | 63,966 | -28.1% | 0.02% | -36.0% |
| Q4 2022 | $947,488 | +44.2% | 88,966 | 0.0% | 0.02% | +38.9% |
| Q3 2022 | $657,000 | +53.5% | 88,966 | 0.0% | 0.02% | +80.0% |
| Q2 2022 | $428,000 | -5.9% | 88,966 | 0.0% | 0.01% | +11.1% |
| Q1 2022 | $455,000 | -15.0% | 88,966 | 0.0% | 0.01% | -10.0% |
| Q4 2021 | $535,000 | -23.7% | 88,966 | +12.4% | 0.01% | -23.1% |
| Q3 2021 | $701,000 | -10.6% | 79,166 | -20.2% | 0.01% | -7.1% |
| Q2 2021 | $784,000 | +21.9% | 99,166 | +17.5% | 0.01% | +16.7% |
| Q1 2021 | $643,000 | +19.7% | 84,399 | +22.5% | 0.01% | +9.1% |
| Q4 2020 | $537,000 | -17.1% | 68,899 | +3.0% | 0.01% | -26.7% |
| Q3 2020 | $648,000 | – | 66,899 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Endurant Capital Management LP | 2,000,000 | $15,240,000 | 3.97% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 45,910 | $350,000 | 0.19% |
| Interchange Capital Partners, LLC | 24,420 | $186,000 | 0.10% |
| GOODWIN DANIEL L | 20,000 | $152,000 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 39,006 | $297,000 | 0.05% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 84,399 | $643,000 | 0.01% |
| BLAIR WILLIAM & CO/IL | 34,766 | $265,000 | 0.00% |
| Hartford Financial Management Inc. | 598 | $5,000 | 0.00% |
| HAP Trading, LLC | 25,100 | $27,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,374 | $11,000 | 0.00% |